Teva Pharmaceutical to invest in Alcobra - MarketLine Financial Deals

Teva Pharmaceutical to invest in Alcobra

Teva Pharmaceutical to invest in Alcobra - MarketLine Financial Deals
Teva Pharmaceutical to invest in Alcobra
Published Feb 22, 2011
2 pages — Published Feb 22, 2011
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

Teva Pharmaceutical Industries, Ltd. has entered into a strategic agreement to invest in Alcobra, Ltd., a company engaged in developing pharmaceutical products for treatment of cognitive impairments.

  
Source:
Document ID
MA68732_110629
Country
Ticker
TEVA=IL
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Teva Pharmaceutical to invest in Alcobra" Feb 22, 2011. Alacra Store. Dec 10, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Teva-Pharmaceutical-to-invest-in-Alcobra-2052-63298>
  
APA:
MarketLine Financial Deals. (2011). Teva Pharmaceutical to invest in Alcobra Feb 22, 2011. New York, NY: Alacra Store. Retrieved Dec 10, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Teva-Pharmaceutical-to-invest-in-Alcobra-2052-63298>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.